{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:28:13Z","timestamp":1761514093456},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T00:00:00Z","timestamp":1509062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"SIMIT 2015 Scholarship for HIV infection"},{"name":"Italian Ministry of Health-INMI \u201cL. Spallanzani\u201d Ricerca Corrente grant"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0187095","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T13:33:04Z","timestamp":1509111184000},"page":"e0187095","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV\/HCV co-infected patients receiving directly-acting antivirals"],"prefix":"10.1371","volume":"12","author":[{"given":"Gabriella","family":"Rozera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Lorenzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Mastrorosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Timelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Zaccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Amendola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Vergori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Maddalena","family":"Plazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Cicalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Antinori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Capobianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Ammassari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,10,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4 T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"D Finzi","year":"1999","journal-title":"Nat Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"N Chomont","year":"2009","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/infdis\/jiv218","article-title":"Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies","volume":"212","author":"AM Crooks","year":"2015","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature16933","article-title":"Persistent HIV-1 replication maintains the tissue reservoir during therapy","volume":"530","author":"R Lorenzo-Redondo","year":"2016","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1128\/JVI.03331-13","article-title":"HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy","volume":"88","author":"JM Murray","year":"2014","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00042560-199812150-00006","article-title":"Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy","volume":"19","author":"J Izopet","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00002030-200401020-00005","article-title":"Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level","volume":"18","author":"JP Viard","year":"2004","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/cid\/ciu585","article-title":"HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy","volume":"59","author":"GJ Besson","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/QAD.0000000000000723","article-title":"Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy","volume":"29","author":"L Cuzin","year":"2015","journal-title":"AIDS"},{"key":"ref10","first-page":"3311","article-title":"HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapinebased regimens","volume":"70","author":"M Kiselinova","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/jac\/dks533","article-title":"Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts","volume":"68","author":"L Hocqueloux","year":"2013","journal-title":"J Antimicrob Chemother."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/cid\/civ171","article-title":"Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA","volume":"60","author":"M Laanani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.antiviral.2015.03.011","article-title":"Hepatitis C therapy with interferon-\u03b1 and ribavirin reduces the CD4 cell count and the total, 2LTR circular and integrated HIV-1 DNA in HIV\/HCV co-infected patients","volume":"118","author":"YM Jiao","year":"2015","journal-title":"Antiviral Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/infdis\/jit628","article-title":"Hepatitis C therapy with interferon-\u03b1 and ribavirin reduces CD4 T-cell-associated HIV-1 DNA in HIV-1\/hepatitis C virus-coinfected patients","volume":"209","author":"H Sun","year":"2014","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/infdis\/jiv521","article-title":"Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+ T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy","volume":"213","author":"S Mor\u00f3n-L\u00f3pez","year":"2016","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2007.0076","article-title":"Interferon may prevent HIV viral rebound after HAART interruption in HIV patients","volume":"28","author":"F Dianzani","year":"2008","journal-title":"J Interferon Cytokine Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/QAD.0b013e32835a5c2f","article-title":"Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials","volume":"26","author":"AM Mexas","year":"2012","journal-title":"AIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/infdis\/jis663","article-title":"Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration","volume":"207","author":"L Azzoni","year":"2013","journal-title":"J Infect Dis"},{"key":"ref19","article-title":"Time course of cellular HIV-1 DNA and low level HIV viremia in HIV-HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals","author":"SG Parisi","year":"2017","journal-title":"Med Microbiol Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e0141164","DOI":"10.1371\/journal.pone.0141164","article-title":"Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV\/HCV Coinfected Patients","volume":"10","author":"I Poizot-Martin","year":"2015","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/apc.2015.0004","article-title":"Majority of HIV\/HCV Patients Need to Switch Antiretroviral Therapy to Accommodate Direct Acting Antivirals","volume":"29","author":"R Cope","year":"2015","journal-title":"AIDS Patient Care STDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1592\/phco.28.1.90","article-title":"Integrase inhibitors: a new treatment option for patients with human immunodeficiency virus infection","volume":"28","author":"T Correll","year":"2008","journal-title":"Pharmacotherapy"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7448\/IAS.17.4.19791","article-title":"Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV-1 RNA","volume":"17","author":"C Bianco","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1742-6405-11-33","article-title":"Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial","volume":"11","author":"A Lafeuillade","year":"2014","journal-title":"AIDS Res Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e31990","DOI":"10.1371\/journal.pone.0031990","article-title":"Switching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNA","volume":"7","author":"YM Lam","year":"2012","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"Recommendations on Treatment of Hepatitis C 2016 European Association for the Study of the Liver","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcv.2011.04.012","article-title":"Standardization and performance evaluation of "modified" and "ultrasensitive" versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia","volume":"52","author":"A Amendola","year":"2011","journal-title":"J Clin Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/71569","article-title":"Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy","volume":"6","author":"ME Sharkey","year":"2000","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3851\/IMP1833","article-title":"Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAART","volume":"16","author":"E Nicastri","year":"2011","journal-title":"Antivir Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2003.02.006","article-title":"Quantification of free circulating DNA as a diagnostic marker in lung cancer","volume":"21","author":"G Sozzi","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1099\/0022-1317-83-1-11","article-title":"Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity","volume":"83","author":"R Curran","year":"2002","journal-title":"J Gen Virol"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/QAI.0b013e31823fd1f2","article-title":"No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy","volume":"59","author":"RT Gandhi","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20121932","article-title":"Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production","volume":"210","author":"M Perreau","year":"2013","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1128\/JVI.00674-16","article-title":"HIV DNA is frequently present within pathologic tissues evaluated at autopsy from combined antiretroviral therapy-treated patients with undetectable viral loads","volume":"90","author":"SL Lamers","year":"2016","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1128\/AAC.00131-11","article-title":"Danoprevir monotherapy decreases inflammatory markers in patients with chronic hepatitis C virus infection","volume":"55","author":"CJ Schaefer","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI5863","article-title":"Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues","volume":"103","author":"RP Bucy","year":"1999","journal-title":"J Clin Invest"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0187095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:28:09Z","timestamp":1540340889000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0187095"}},"subtitle":[],"editor":[{"given":"Alan","family":"Landay","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,27]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0187095","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,27]]}}}